Showing results (191-200 of 266) with videos related to
Sort By:
Pageof 27
Tissue Antigens|December 1, 1996
Functional significance of polymorphism among MHC class II gene promotersJ Guardiola, A Maffei, R Lauster, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 2, 1998
Metronidazole has no antibacterial effect in Cornell model murine tuberculosisJ Dhillon, B W Allen, Y M Hu, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1986
Molecular mapping of idiotopes of anti-arsonate antibodiesD Jeske, E C Milner, O Leo, et al.Journal of Veterinary Emergency and Critical Care (San Antonio, Tex. : 2001)|April 30, 2023
Surgical interventions and outcome in a population of feline trauma patientsCorey J Fisher, Amanda A Cavanagh, David Liss, et al.British Medical Journal|May 28, 1977
Evaluation of a serological test for tuberculosisD A Mitchison, V R Aber, F J Ahmad, et al.Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1993
Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapyS Das, S L Chan, B W Allen, et al.British Medical Journal|August 29, 1970
Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazidK V Rao, D A Mitchison, N G Nair, et al.Antimicrobial Agents and Chemotherapy|October 1, 1996
Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosisD Herbert, C N Paramasivan, P Venkatesan, et al.Diabetes|April 1, 1985
Albumin permeation of new vessels is increased in diabetic ratsP Kilzer, K Chang, J Marvel, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 24, 1998
Bioavailability of Chinese rifapentine during a clinical trial in Hong KongC M Tam, S L Chan, C W Lam, et al.Pageof 27